Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury
The Lancet Microbe · 2026-10 · 7 (10) · 101499
DOI: 10.1016/j.lanmic.2026.101499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026-10. Verfasst von Adrien Lupieri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Excellence in Vascular Biology, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, T-Lymphocytes, Cytokines, Heart Valves. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation Leducq.
Abstract (Originalsprache)
Acute rheumatic fever is an immune-mediated sequela of Streptococcus pyogenes (group A Streptococcus) infection, presenting with fever, arthritis, chorea, rash, and, crucially, carditis. Without effective secondary prophylaxis and care, acute rheumatic fever can progress to chronic rheumatic heart disease, a leading yet under-recognised cause of cardiovascular morbidity and death that disproportionately affects children and young adults aged 5-24 years in low-resource settings. Robust evidence implicates the role of antigenic mimicry-particularly between streptococcal M protein and cardiac or myocardial matrix proteins-together with dysregulated immune control in driving valvular injury. In this Review, we discussed mechanisms of rheumatic heart disease immunopathogenesis, highlighting the roles of T-cell responses, chemokine-guided recruitment to valves, cytokine dysregulation, endothelial activation, and stromal remodelling. We also analysed limitations of existing data and delineate strategies to develop experimental models, identify biomarkers, and define immunomodulatory targets that can inform earlier diagnosis, enhanced secondary prevention, and rational therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Excellence in Vascular Biology, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.
- Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Division of Host-Microbe Systems & Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego…
- Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Center for Excellence in Vascular Biology, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Center for Interdisciplinary Cardiovascular Sciences, Division of Ca…
Förderung
- Fondation Leducq
Zitieren
APA
Lupieri, A., Diaz, J. M., Moreira, T. B., Jacaúna, A., McCormick, J. K., Nizet, V., Levine, R. A., Aikawa, E., Dutra, W. O., & Leducq PRIMA (Preventing Rheumatic Injury bioMarker Alliance) Network (2026). Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury. The Lancet Microbe, 7(10), 101499. https://doi.org/10.1016/j.lanmic.2026.101499
Vancouver
Lupieri A, Diaz JM, Moreira TB, Jacaúna A, McCormick JK, Nizet V, et al. Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury. The Lancet Microbe. 2026;7(10):101499. doi:10.1016/j.lanmic.2026.101499
BibTeX
@article{Lupieri2026,
author = {Lupieri, Adrien and Diaz, Juan Manuel and Moreira, Thayse Batista and Jacaúna, Adriana and McCormick, John K and Nizet, Victor and Levine, Robert A and Aikawa, Elena and Dutra, Walderez O and Leducq PRIMA (Preventing Rheumatic Injury bioMarker Alliance) Network, Leducq PRIMA (Preventing Rheumatic Injury bioMarker Alliance) Network},
title = {Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {10},
pages = {101499},
doi = {10.1016/j.lanmic.2026.101499}
}
EUVIMED